Galera (Nasdaq: GRTX), which develops treatments to reduce the harmful effect of radiation therapy, reached a major milestone in November 2019 when it raised net proceeds of $58.1 million by selling 5.4 million shares of its common stock in an IPO…
Galera (Nasdaq: GRTX), which develops treatments to reduce the harmful effect of radiation therapy, reached a major milestone in November 2019 when it raised net proceeds of $58.1 million by selling 5.4 million shares of its common stock in an IPO…